Search Results
Jul 08, 2026, 08:00 ET Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome
"Company" or "Mighty"), a commercial-stage biotechnology company pioneering a new class of medicines that directly target mitochondrial dysfunction in rare and age-related diseases, today announced that the first patient has been dosed in 4TAZPower, its global Phase 4 study to confirm the efficacy, safety,
More news about: Mighty Therapeutics
Jul 08, 2026, 08:00 ET Tronox Announces Dates for Second Quarter 2026 Earnings Release & Webcast Conference Call
titanium-bearing mineral sands and operate upgrading facilities that produce high-grade titanium feedstock materials, pig iron and other minerals, including the rare earth-bearing mineral, monazite. With approximately 5,700 employees across six continents, our rich diversity, unmatched vertical integration model,
More news about: Tronox Holdings plc
Jul 08, 2026, 07:05 ET LAKRIDS BY BÜLOW DELIVERS 19% GROWTH IN 2025 AS GLOBAL MOMENTUM ACCELERATES
digital development and product quality. Our retail stores performed exceptionally well, our online business now represents 35% of total sales, which is rare in the confectionery category, and our B2B channel grew strongly as we added several prestigious partners." He continues: "To support
More news about: LAKRIDS BY BÜLOW
Jul 08, 2026, 07:00 ET Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis
KeenovaKeenova Therapeutics is a leading U.S.-focused branded therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives.Keenova's rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of specialty
More news about: Keenova Therapeutics
Jul 08, 2026, 07:00 ET BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology company developing novel small molecule therapeutics, today announced highly encouraging new
More news about: BioLineRx Ltd.; Hemispherian AS
Jul 08, 2026, 07:00 ET Alta Raises $25M to Redefine the Go-to-Market Architecture for Revenue Teams
global reach.""Having worked closely with Stav at monday.com, I knew firsthand her rare ability to turn complex data into explosive growth," said Avi Eyal, Managing Partner at Entrée Capital. The Alta team is not just building
More news about: Alta
Jul 08, 2026, 05:59 ET Forevermark Diamond Jewellery Presents an Exclusive ICON Bracelet Inspired by Indian Cricketer Abhishek Sharma
of diamonds. Every Forevermark Diamond Jewellery creation celebrates life's most meaningful moments, featuring natural diamonds that are beautiful, rare and responsibly sourced. Every Forevermark diamond bears a unique inscription, ensuring authenticity and making each piece deeply personal.Formed
More news about: Forevermark Diamond Jewellery
Jul 08, 2026, 05:03 ET Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy
July 8, 2026 /PRNewswire/ -- Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat,
More news about: Grünenthal Group
Jul 08, 2026, 03:00 ET Tethis expands global access to SmartBioSurface® through new channel partners in Brazil, India, China and South Africa
high-quality preparation of rare and suspension cells in cutting-edge research fields such as liquid biopsy, immunology, and single-cell analysis.Supporting advanced cellular analysis worldwideSmartBioSurface slides enable reproducible preparation of suspension and rare cells, overcoming limitations
More news about: Tethis S.p.A
Jul 08, 2026, 03:00 ET Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
about us at www.genespire.com.About methylmalonic acidemia (MMA)MMA is a rare, genetic metabolic disorder most frequently caused by a faulty gene coding for the mitochondrial enzyme methylmalonyl-coA mutase (MUT). Persons with
More news about: Genespire
Jul 08, 2026, 00:01 ET As Ebola Surges, 3 in 4 Americans Back Restoring U.S. Aid to Fight It, per New Echelon-Rockefeller Foundation Poll
the spread of seven outbreaks, saving countless lives. In 2026, the World Health Organization declared a new Ebola outbreak in the Congo, featuring a rare and especially lethal strain of the virus. Health experts have pointed to cuts in U.S. funding for disease monitoring and pandemic response as key factors
More news about: The Rockefeller Foundation
Jul 08, 2026, 00:01 ET As Ebola Surges, 3 in 4 Americans Back Restoring U.S. Aid to Fight It, per New Echelon-Rockefeller Foundation Poll
the spread of seven outbreaks, saving countless lives. In 2026, the World Health Organization declared a new Ebola outbreak in the Congo, featuring a rare and especially lethal strain of the virus. Health experts have pointed to cuts in U.S. funding for disease monitoring and pandemic response as key factors
More news about: The Rockefeller Foundation
Jul 07, 2026, 16:30 ET Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S
Chairman of Vanda. "The FDA's Rare Pediatric Disease Designation recognizes the significant unmet medical need in this patient population and supports our efforts to develop a potentially transformative therapy for patients affected by this rare disease."CMT2S is a rare genetic disorder characterized
More news about: Vanda Pharmaceuticals Inc.
Jul 07, 2026, 15:33 ET GLOBAL BATTERY MATERIALS ANNOUNCES POSITIVE PRELIMINARY ECONOMIC ASSESSMENT FOR THE KEARNEY GRAPHITE PROJECT
results, Eric Miller, Chief Executive Officer of Global Battery Materials Corp., stated:"The Kearney Graphite Project represents a rare opportunity to establish domestic graphite production quickly and with capital efficiency," said Eric Miller, CEO of GBM. "The mine has a proven history
More news about: Global Battery Materials
Jul 07, 2026, 14:35 ET Can $2,500 and a Smartphone App Double the Success of Sight-Restoring Surgery? New Orbis International Study Says Yes
advanced technology—sometimes basic tools and skills are enough."A Tale of Two Countries: The Zambia LessonThe study also provides a rare, candid look at the logistical "last mile" of global health. While Ethiopia saw rapid success, five partner hospitals in Zambia faced significant delays
More news about: Orbis International
Jul 07, 2026, 13:10 ET THE ONLY AGENCY APPOINTS NATE YOHANNES AND CHRISTY HAUBEGGER TO BOARD OF DIRECTORS
in Technology Leadership at Brown University and a JD from University at Buffalo School of Law."The Only Agency sits at a rare intersection of culture, commerce, and creativity. I'm honored to join its board at this pivotal moment and look forward to helping the team harness
More news about: The Only Agency
Jul 07, 2026, 13:04 ET Pebble Beach Automotive Week Hosts Automobili Lamborghini's Celebration of its Miura
location, surpassing previous gatherings for the model's 40th and 50th anniversaries. Enthusiasts attending Pebble Beach Automotive Week will have the rare opportunity to view this unprecedented collection of groundbreaking automobiles and connect with many of the world's most respected Miura cognoscenti."Part
More news about: Pebble Beach Concours d'Elegance
Jul 07, 2026, 12:53 ET WGS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages WGS Investors with Losses to Contact the Firm
HOLDINGS CORP. CLASS ACTION LAWSUIT – COMPLAINT ALLEGATION SUMMARY:GeneDx provides genetic testing services for diagnosing pediatric and rare diseases. The class period begins on April 16, 2025, when GeneDx announced that it entered into an agreement worth up to $51 million to acquire Fabric
More news about: Kessler Topaz Meltzer & Check, LLP
Jul 07, 2026, 12:16 ET M1X Global Announces Further Funding Led by Paradigm, Totalling $8.5 Million
"24/7 markets require collateral that can move 24/7. USDM1 shows how sovereign debt can be issued natively onchain. M1X Global has assembled the rare mix of government, capital markets, and crypto expertise needed to bring this model to institutional scale." The raise also
More news about: M1X Global
Jul 07, 2026, 12:00 ET FGV Study Identifies Brazil's Potential to Become a Global Digital Infrastructure Hub
Luciano Fialho, Corporate Senior Vice President at Scala Data Centers. "Those constraints create an opening for new global hubs. Brazil offers a rare combination of large-scale energy availability, a predominantly renewable power matrix, significant expansion potential, abundant land, and strong connectivity
More news about: Scala Data Centers
Jul 07, 2026, 11:30 ET Introducing Nell Hotels: Bringing the Legacy of Aspen's The Little Nell to Rockefeller Center with the Debut of The Nell New York
service, and a deep connection to the city around it. A seventh-floor arrival experience will lift guests above the pace of the city entirely, creating a rare sense of discretion and calm within one of the world's most visited destinations and most beloved cultural landmarks, home to the Christmas Tree, the
More news about: Aspen One
Jul 07, 2026, 11:17 ET MAIN STREET SMILES FIRST IN BARRINGTON TO OFFER BREAKTHROUGH TECHNOLOGY FOR TMJ RELIEF AND FACIAL REJUVENATION
completely new, noninvasive option to help relax overworked muscles, improve blood flow and reduce discomfort while also delivering aesthetic benefits. It's rare to find a treatment that can improve both function and appearance at the same time."TMJ affects millions of Americans and can cause chronic facial
More news about: Main Street Smiles
Jul 07, 2026, 11:09 ET Peabody Awarded Grant from U.S. Department of Energy to Advance Domestic Rare Earth and Critical Mineral Supply Chain
Department of Energy has selected the company for funding to advance the production of rare earth elements and critical minerals. The selection supports Peabody's ongoing efforts to evaluate and advance the recovery of rare earth elements and critical minerals from its extensive resource base in Wyoming's
More news about: Peabody
Jul 07, 2026, 11:08 ET Gravity Game Unite Resmi Buka Open Beta Test Kedua Ragnarok Zero: Global untuk PC
Unite menyiapkan berbagai event komunitas, antara lain:Melakukan praregistrasi untuk kedua game dan mendapatkan Rare Poring Egg di Get Poring.Mencapai level maksimum selama OBT2 untuk memperoleh Valhalla Pass yang dapat digunakan untuk memindahkan
More news about: Gravity Game Unite SDN. BHD.
Jul 07, 2026, 10:31 ET Post-Bariatric Hypoglycemia Market to Register Stunning Growth at a 16.4% CAGR Through 2036 Owing to the Emergence of Novel Drug Classes Such as GLP-1 Receptor Antagonists, SGLT1 Inhibitors, CRH Inhibitors, and SSTR5 Agonists | DelveInsight
managed through dietary modifications, such as consuming frequent low-glycemic meals rich in protein and fiber, while pharmacological therapies and, in rare refractory cases, surgical interventions may be required for persistent symptoms.Post-Bariatric Hypoglycemia Epidemiology SegmentationThe
More news about: DelveInsight Business Research, LLP